1-3 of 3
Anne H. Loonen
Close
Sort by
Journal Articles

Does modulation of P-glycoprotein have clinical relevance in pediatric acute myeloid leukemia?

Christian Michel Zwaan, Monique L. den Boer, Karin M. Kazemier, Karel Hählen, Anne H. Loonen, Dirk Reinhardt, Ursula Creutzig, Gertjan J. L. Kaspers, Rob Pieters
Journal: Blood
Blood (2006) 107 (12): 4975–4977.
https://doi.org/10.1182/blood-2006-01-0309
Published: 2006
Journal Articles

Large Interindividual Differences in In Vitro Calicheamicin Sensitivity May Underly Gemtuzumab Ozogamicin Resistance in Acute Myeloid Leukemia (AML).

Bianca F. Goemans, MD, Gertjan J.L. Kaspers, MD, PhD, Susanne J.H. Vijverberg, BSc, Anne H. Loonen, Ursula Creutzig, MD, PhD, Karel Hahlen, MD, PhD, Dirk Reinhardt, MD, PhD, Brenda E.S. Gibson, MD, PhD, Jacqueline Cloos, PhD, Christian M. Zwaan, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 107.
https://doi.org/10.1182/blood.V106.11.107.107
Published: 2005
Journal Articles

In vitro profiling of the sensitivity of pediatric leukemia cells to tipifarnib: identification of T-cell ALL and FAB M5 AML as the most sensitive subsets

Bianca F. Goemans, Christian M. Zwaan, Amy Harlow, Anne H. Loonen, Brenda E. S. Gibson, Karel Hählen, Dirk Reinhardt, Ursula Creutzig, Michael C. Heinrich, Gertjan J. L. Kaspers
Journal: Blood
Blood (2005) 106 (10): 3532–3537.
https://doi.org/10.1182/blood-2005-04-1640
Published: 2005